Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-04-005028
Filing Date
2004-02-18
Accepted
2004-02-18 18:26:09
Documents
1
Period of Report
2004-02-17

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3813
  Complete submission text file 0001104659-04-005028.txt   5616
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Issuer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address C/O NEOPHARM INC 150 FIELD DRIVE STE 195 LAKE FOREST IL 60045 8472958678
SHERMAN JEFFREY W (Reporting) CIK: 0001230482 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12493 | Film No.: 04614235